ReviewOncoTargets and therapy2026

Enhancing Immunotherapy in Diffuse Large B-Cell Lymphoma: The Synergistic Potential of Metabolic Checkpoint Inhibitors and Immunomodulation.

Meghana K Rajendraprasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.